Aneta Szudy-Szczyrek (A Szudy-Szczyrek)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 24

Top Topics

Multiple Myeloma

Top Venues

Journal of clinical medicine

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Beata Biernacka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Wojciech Styk, Joanna Czerwik-Marcinkowska, Grazyna Swiderska-Kolacz
In Vitro Low-Bortezomib Doses Induce Apoptosis and Independently Decrease the Activities of Glutathione S-Transferase and Glutathione Peroxidase in Multiple Myeloma, Taking into Account the GSTT1 and GSTM1 Gene Variants. Genes 15 (3) (2024)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 12 (6) (2023)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 12 (6) (2023)
Michał Szczyrek, Paulina Bitkowska, Marta Jutrzenka, Aneta Szudy-Szczyrek, Anna Drelich-Zbroja, Janusz Milanowski
Pleural Neoplasms-What Could MRI Change? Cancers 15 (12) (2023)
Michał Mielnik, Aneta Szudy-Szczyrek, Iwona Homa-Mlak, Radosław Mlak, Martyna Podgajna, Aneta Gorący, Teresa Małecka-Massalska, Marek Hus
The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients. Biomedicines 11 (11) (2023)
Aneta Szudy-Szczyrek, Radosław Mlak, Marcin Mazurek, Tomasz Krajka, Sylwia Chocholska, Paulina Bitkowska, Marta Jutrzenka, Michał Szczyrek, Iwona Homa-Mlak, Andrzej Krajka, Teresa Małecka-Massalska, Marek Hus
The TT Genotype of the KIAA1524 rs2278911 Polymorphism Is Associated with Poor Prognosis in Multiple Myeloma. Cells 12 (7) (2023)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Sylwia Chocholska, Aneta Szudy-Szczyrek, Marzena Samardakiewicz, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
Association of Chromosome 17 Aneuploidy, TP53 Deletion, Expression and Its rs1042522 Variant with Multiple Myeloma Risk and Response to Thalidomide/Bortezomib Treatment. Cancers 15 (19) (2023)
Michał Szczyrek, Paulina Bitkowska, Marta Jutrzenka, Aneta Szudy-Szczyrek, Anna Drelich-Zbroja, Janusz Milanowski
Pleural Neoplasms-What Could MRI Change? Cancers 15 (12) (2023)
Sylwia Popek-Marciniec, Wojciech Styk, Magdalena Wojcierowska-Litwin, Aneta Szudy-Szczyrek, Paul Dudek, Grazyna Swiderska-Kolacz, Joanna Czerwik-Marcinkowska, Szymon Zmorzynski
The Relationship of CCL5 and CCR1 Variants with Response Rate and Survival Taking into Account Thalidomide/Bortezomib Treatment in Patients with Multiple Myeloma. Journal of clinical medicine 12 (6) (2023)
Aneta Szudy-Szczyrek, Sean Ahern, Janusz Krawczyk, Michał Szczyrek, Marek Hus
MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives. Journal of personalized medicine 12 (9) (2022)
Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, Marcin Mazurek, Sylwia Chocholska, Martyna Podgajna, Michał Szczyrek, Iwona Homa-Mlak, Teresa Małecka-Massalska, Marek Hus
Circulating Serum MiRNA-8074 as a Novel Prognostic Biomarker for Multiple Myeloma. Cells 11 (4) (2022)
Aneta Szudy-Szczyrek, Oliwia Bachanek-Mitura, Tomasz Gromek, Karolina Chromik, Andrzej Mital, Michał Szczyrek, Witold Krupski, Justyna Szumiło, Zuzanna Kanduła, Grzegorz Helbig, Marek Hus
Real-World Efficacy of Midostaurin in Aggressive Systemic Mastocytosis. Journal of clinical medicine 10 (5) (2021)
Aneta Szudy-Szczyrek, Sean Ahern, Magdalena Kozioł, Daria Majowicz, Michał Szczyrek, Janusz Krawczyk, Marek Hus
Therapeutic Potential of Innate Lymphoid Cells for Multiple Myeloma Therapy. Cancers 13 (19) (2021)
Magdalena Bury-Kamińska, Aneta Szudy-Szczyrek, Aleksandra Nowaczyńska, Olga Jankowska-Łęcka, Marek Hus, Klaudia Kot
Chemotherapy-Related Differences in Cognitive Functioning and Their Biological Predictors in Patients with Multiple Myeloma. Brain sciences 11 (9) (2021)
Iwona Homa-Mlak, Anna Brzozowska, Radosław Mlak, Aneta Szudy-Szczyrek, Teresa Małecka-Massalska
Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy. Journal of clinical medicine 10 (19) (2021)
Michał Szczyrek, Anna Grenda, Barbara Kuźnar-Kamińska, Paweł Krawczyk, Marek Sawicki, Halina Batura-Gabryel, Radosław Mlak, Aneta Szudy-Szczyrek, Tomasz Krajka, Andrzej Krajka, Janusz Milanowski
Methylation of DROSHA and DICER as a Biomarker for the Detection of Lung Cancer. Cancers 13 (23) (2021)
Szymon Zmorzynski, Magdalena Wojcierowska-Litwin, Sylwia Popek-Marciniec, Aneta Szudy-Szczyrek, Wojciech Styk, Sylwia Chocholska, Agata Anna Filip
The Relationship of ABCB1/MDR1 and CYP1A1 Variants with the Risk of Disease Development and Shortening of Overall Survival in Patients with Multiple Myeloma. Journal of clinical medicine 10 (22) (2021)
Aneta Szudy-Szczyrek, Radosław Mlak, Magdalena Bury-Kamińska, Michał Mielnik, Martyna Podgajna, Kinga Kuśmierczuk, Marcin Mazurek, Iwona Homa-Mlak, Michał Szczyrek, Janusz Krawczyk, Teresa Malecka-Massalska, Marek Hus
Serum brain-derived neurotrophic factor (BDNF) concentration predicts polyneuropathy and overall survival in multiple myeloma patients. British journal of haematology 191 (1) (2020)
Szymon Zmorzyński, Sylwia Popek-Marciniec, Wojciech Styk, M Wojcierowska-Litwin, I Korszeń-Pilecka, Aneta Szudy-Szczyrek, Sylwia Chocholska, Marek Hus, Agata Anna Filip
The Impact of the NOD2/CARD15 Variant (3020insC) and PSMA6 Polymorphism (-8C>G) on the Development and Outcome of Multiple Myeloma. BioMed research international 2020 (2020)
Aneta Szudy-Szczyrek, Radosław Mlak, Michał Mielnik, Michał Szczyrek, Aleksandra Nowaczyńska, Iwona Homa-Mlak, Szymon Zmorzyński, Kinga Kuśmierczuk, Jacek Sompor, Agata Filip, Teresa Małecka-Massalska, Marek Hus
Prognostic value of pretreatment neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in multiple myeloma patients treated with thalidomide-based regimen. Annals of hematology 99 (12) (2020)
Radosław Mlak, Aneta Szudy-Szczyrek, Marcin Mazurek, Michał Szczyrek, Iwona Homa-Mlak, Michał Mielnik, Sylwia Chocholska, Olga Jankowska-Łęcka, Teresa Małecka-Massalska, Marek Hus
Polymorphisms in the promotor region of the CRBN gene as a predictive factor for peripheral neuropathy in the course of thalidomide-based chemotherapy in multiple myeloma patients. British journal of haematology 186 (5) (2019)